These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31444033)

  • 1. Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.
    Nezos A; Evangelopoulos ME; Mavragani CP
    J Autoimmun; 2019 Nov; 104():102317. PubMed ID: 31444033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis.
    Giannelou M; Nezos A; Fragkioudaki S; Kasara D; Maselou K; Drakoulis N; Ioakeimidis D; Moutsopoulos HM; Mavragani CP
    Clin Immunol; 2018 Aug; 193():110-117. PubMed ID: 29501539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
    Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
    Szodoray P; Jonsson R
    Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren's syndrome: the impact of BAFF genetic variations.
    Kintrilis N; Gravani F; Rapti A; Papaioannou M; Flessa CM; Nezos A; Antypa E; Papadaki I; Karageorgas Τ; Moutsopoulos HM; Mavragani CP
    Rheumatology (Oxford); 2023 Feb; 62(2):958-968. PubMed ID: 35689637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAFF overexpression is associated with autoantibody production in autoimmune diseases.
    Pers JO; Daridon C; Devauchelle V; Jousse S; Saraux A; Jamin C; Youinou P
    Ann N Y Acad Sci; 2005 Jun; 1050():34-9. PubMed ID: 16014518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of BAFF in autoimmune diseases].
    Matsushita T; Sato S
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Oct; 28(5):333-42. PubMed ID: 16276047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity].
    Vadacca M; Margiotta D; Sambataro D; Buzzulini F; Lo Vullo M; Rigon A; Afeltra A
    Reumatismo; 2010; 62(4):259-65. PubMed ID: 21253619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.
    Argyriou E; Nezos A; Roussos P; Venetsanopoulou A; Voulgarelis M; Boki K; Tzioufas AG; Moutsopoulos HM; Mavragani CP
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33567548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies - novel tool for diagnostics and patient follow-up.
    Osnes LT; Nakken B; Bodolay E; Szodoray P
    Autoimmun Rev; 2013 Aug; 12(10):967-71. PubMed ID: 23541481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.
    Batten M; Fletcher C; Ng LG; Groom J; Wheway J; Laâbi Y; Xin X; Schneider P; Tschopp J; Mackay CR; Mackay F
    J Immunol; 2004 Jan; 172(2):812-22. PubMed ID: 14707051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
    Ciccacci C; Latini A; Perricone C; Conigliaro P; Colafrancesco S; Ceccarelli F; Priori R; Conti F; Perricone R; Novelli G; Borgiani P
    J Immunol Res; 2019; 2019():6728694. PubMed ID: 31534975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.
    Samy E; Wax S; Huard B; Hess H; Schneider P
    Int Rev Immunol; 2017 Jan; 36(1):3-19. PubMed ID: 28215100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.